Gilead settles patent disputes over Biktarvy with generic drugmakers

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/29/2026

1. WDAY
2. ESTC
3. MRVL
4. AFRM
5. RBRK
6. S
7. GAP
8. DG
9. ULTA
10. NVDA

Go back to Gilead settles patent disputes over Biktarvy with generic drugmakers
Gilead Sciences (NASDAQ: GILD) Delayed: 145.68 -3.18 (2.14%)
Previous Close $148.86    52 Week High $108.63 
Open $149.47    52 Week Low $71.39 
Day High $149.47    P/E 80.49 
Day Low $144.88    EPS $1.81 
Volume 3,946,913